Division of Pediatric Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Ege University, Izmir, Turkey.
Department of Pediatric Cardiology, Faculty of Medicine, Ege University, Izmir, Turkey.
Cardiol Young. 2023 Apr;33(4):525-531. doi: 10.1017/S1047951123000100. Epub 2023 Jan 23.
Cardiac manifestations of the coronavirus disease 2019 (COVID-19) have mainly been reported in adults. Therefore, we aimed to determine the electrocardiographic abnormalities in hospitalised paediatric patients with COVID-19 and multisystemic inflammatory syndrome in children.
We retrospectively evaluated hospitalised paediatric patients <18 years of age with a diagnosis of COVID-19 (n = 168) and multisystem inflammatory syndrome in children (n = 48) between March 2021 and December 2021. A daily electrocardiography was performed for the patients who had electrocardiographic abnormalities on admission or developed electrocardiographic abnormality on the follow-up. The characteristics of these patients, underlying predisposing conditions, and clinical course were also examined.
Two-hundred sixteen paediatric patients (55% were male) with a mean age of 10.7 ± 4.69 years were evaluated. There was an underlying disease in 84 (38.8%) patients and 51 (23.6%) required paediatric ICU admission. Electrocardiography abnormality was detected in 12 (5.5%) which were as follows: 7 (3.2%) had sinus bradycardia, 3 (1.4%) patients had transient ST elevation and concomitant T negativity, and 2 (0.9%) developed first-degree Atrioventricular (AV) block. The median time from the onset of disease symptoms to detecting electrocardiographic abnormality was 9 days. Electrocardiographic abnormalities returned to normal uneventfully 3 days later.
The prevalence of arrhythmia in paediatric patients with COVID-19 was detected in 5.5% of the patients. While two-thirds of the electrocardiography abnormalities were sinus bradycardia, ST elevation was remarkable (1.4%). Clinicians should be aware of electrocardiographic abnormalities and consider electrocardiographic monitoring in paediatric patients with COVID-19 and multisystemic inflammatory syndrome in children.
冠状病毒病 2019(COVID-19)的心脏表现主要在成人中报道。因此,我们旨在确定住院的 COVID-19 患儿和儿童多系统炎症综合征患者的心电图异常。
我们回顾性评估了 2021 年 3 月至 2021 年 12 月期间诊断为 COVID-19(n=168)和儿童多系统炎症综合征(n=48)的<18 岁住院儿科患者。对入院时心电图异常或随访时出现心电图异常的患者进行每日心电图检查。还检查了这些患者的特征、潜在的诱发条件和临床过程。
评估了 216 名儿科患者(55%为男性),平均年龄为 10.7±4.69 岁。84 名患者有基础疾病,51 名(23.6%)需要儿科 ICU 入院。12 名(5.5%)患者发现心电图异常,分别为:7 名(3.2%)窦性心动过缓,3 名(1.4%)患者短暂性 ST 段抬高伴同时 T 波倒置,2 名(0.9%)发生一度房室(AV)传导阻滞。从疾病症状发作到检测到心电图异常的中位数时间为 9 天。3 天后心电图异常恢复正常。
在 COVID-19 患儿中,心律失常的发生率为 5.5%。尽管三分之二的心电图异常为窦性心动过缓,但 ST 段抬高较为显著(1.4%)。临床医生应注意心电图异常,并考虑对 COVID-19 患儿和儿童多系统炎症综合征患者进行心电图监测。